IOP Announces the Promotion of Daniel Mathot to Assistant Product Manager
COSTA MESA, California – 1 December 2005 – IOP Ophthalmics, the premier developer and distributor of specialty surgical technologies for eye surgery, announced today the promotion of Daniel Mathot to Assistant Product Manager. This new appointment is effective immediately.
Daniel initially joined IOP in 1999 as a customer service representative. He quickly established himself as a leader in customer care services and the management of customer-related issues. In 2002, he was promoted to Customer Service Supervisor. During Mathot’s tenure in customer service, IOP Ophthalmics experienced rapid, dramatic revenue and business growth. Concurrently, Daniel demonstrated unyielding dedication and commitment to maintaining superior customer service in the face of such rapid expansion.
His new position with the company will allow IOP Ophthalmics to benefit from Daniel’s focus, organization and energy. He will be responsible for assisting the company’s rapidly expanding product development and management functions.
Comments from Erich Ziegler, Vice President: “We are a blessed organization. Every member of the IOP team is committed to and focused on our deep sense of purpose. No teammate better symbolizes and emphasizes our corporate culture than Daniel Mathot. Daniel will flourish in his new capacity at the company. And, ultimately, the entire organization – and our customers – will benefit by Dan’s personal progress.”
Dan, a resident of Costa Mesa CA, is a competitive triathlete – and is engaged to married to Sarah Hewitt. The wedding is set for September 2006.
Founded in 1988, IOP Ophthalmics develops and commercializes specialized, leading-edge surgical technologies for eye surgery. IOP’s purpose is to develop surgical solutions that improve the quality of life for patients, elevate the performance and productivity of eye care professionals, and lower costs to the provider.
IOP currently holds leadership positions with surgical devices for oculoplastic surgeries and bio-implant technologies for cornea, anterior and oculoplastic surgeries.